DNA Repair Targeted Therapy: New Advances in Cancer Treatment

Dear Colleagues,

Cancer treatment has seen a revolutionary shift with the recognition of DNA repair mechanisms in tumor cells. Over time, understanding how these repair processes safeguard cancer cells from traditional therapies has become a focal point for improving treatment efficacy.

The aim of this Special Issue is to showcase the latest breakthroughs in DNA repair-targeted cancer therapy. It will cover research on novel molecular targets involved in DNA repair pathways, the development of drugs that specifically disrupt these pathways, and the evaluation of combination therapies with existing cancer treatments.

Cutting-edge research in this field includes the utilization of gene-editing technologies like CRISPR-Cas systems to manipulate DNA repair genes in cancer cells. Additionally, the exploration of immune-based therapies in combination with DNA repair inhibitors, leveraging the body's immune system to enhance the effects of targeting DNA repair processes.

We are interested in original research articles, in-depth reviews, and case reports that present new findings on DNA repair-targeted therapies. Papers highlighting pre-clinical studies, clinical trial results, or innovative drug development strategies are highly encouraged.

Dr. Nimrat Chatterjee
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.